Basic Information
RNALocate ID: RLID:11002591
RNA Symbol: hsa-miR-342-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-342-3p
RNA ID: miRBase:MIMAT0000753
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 24009880
Tissue/Cell Line: Human mast cell line (HMC-1)
Method: Microarray
Description: In the exosomes, 116 microRNAs were identified and 134 microRNAs were identified in the donor HMC-1 cells (Fig. 3a and 3b, Table I and Additional Information, Table S16). Data are collected from Table 1.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002053 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01002054 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01002055 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01002056 Nucleolus HeLa cells 23940654
RLID:01002057 Nucleolus Breast adenocarcinoma cells (MCF-7) 24918059
RLID:01002058 Nucleus Neural progenitor cells 21363885
RLID:11002584 Exosome Serum 18589210
RLID:11002585 Exosome Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11002586 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11002587 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11002588 Exosome Renal cancer cells 21670082
RLID:11002589 Exosome Brain tissue 23382797
RLID:11002590 Exosome Plasma 23663360
RLID:11002592 Exosome Serum 25349172
RLID:11002593 Microvesicle Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11002594 Microvesicle Seminal plasma 23539611
RLID:11002595 Microvesicle Follicular fluid 23666971
RLID-D:11000129 Exosome B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Mast cells|Seminal fluid
RLID-D:11000430 Microvesicle Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-342-3p Diffuse large b cell lymphoma MNDR-E-MI-42082
MNDR hsa-miR-342-3p Splenic marginal zone lymphoma MNDR-E-MI-42083
MNDR hsa-miR-342-3p Multiple sclerosis chronic progressive MNDR-E-MI-42084
MNDR hsa-miR-342-3p Oral squamous cell carcinoma MNDR-E-MI-42085
MNDR hsa-miR-342-3p B cell lymphoma of malt type MNDR-E-MI-42086
MNDR hsa-miR-342-3p Lymphoma MNDR-E-MI-42087
MNDR hsa-miR-342-3p Lymphoma non-hodgkin MNDR-E-MI-42088
MNDR hsa-miR-342-3p Cutaneous t cell lymphoma MNDR-E-MI-42089
MNDR hsa-miR-342-3p Estrogen-receptor positive breast cancer MNDR-E-MI-42090
MNDR hsa-miR-342-3p Progesterone-receptor positive breast cancer MNDR-E-MI-42091
MNDR hsa-miR-342-3p Progesterone-receptor negative breast cancer MNDR-E-MI-42092
MNDR hsa-miR-342-3p Acute promyelocytic leukemia MNDR-E-MI-42093
MNDR hsa-miR-342-3p Breast cancer luminal MNDR-E-MI-42094
MNDR hsa-miR-342-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-42095
MNDR hsa-miR-342-3p B cell acute lymphoblastic leukemia MNDR-E-MI-42096
MNDR hsa-miR-342-3p Prostate cancer MNDR-E-MI-42097
MNDR hsa-miR-342-3p Gastric cancer MNDR-E-MI-42098
MNDR hsa-miR-342-3p Gastric lymphoma MNDR-E-MI-42099
MNDR hsa-miR-342-3p Alzheimer disease MNDR-E-MI-42100
MNDR hsa-miR-342-3p Intracranial aneurysm MNDR-E-MI-42101
MNDR hsa-miR-342-3p Dysautonomia familial MNDR-E-MI-42102
MNDR hsa-miR-342-3p Head and neck cancer MNDR-E-MI-42103
MNDR hsa-miR-342-3p Leukemia MNDR-E-MI-42104
MNDR hsa-miR-342-3p Huntington disease MNDR-E-MI-42105
MNDR hsa-miR-342-3p Chorea MNDR-E-MI-42106
MNDR hsa-miR-342-3p Cardiovascular disease MNDR-E-MI-42107
MNDR hsa-miR-342-3p Neurodegenerative diseases MNDR-E-MI-42108
MNDR hsa-miR-342-3p Lung cancer MNDR-E-MI-42109
MNDR hsa-miR-342-3p Parkinson disease MNDR-E-MI-42110
MNDR hsa-miR-342-3p Machado-joseph disease MNDR-E-MI-42111
MNDR hsa-miR-342-3p Breast cancer MNDR-E-MI-42112
MNDR hsa-miR-342-3p Pancreatic cancer MNDR-E-MI-42113
MNDR hsa-miR-342-3p Rectum adenocarcinoma MNDR-E-MI-42114
MNDR hsa-miR-342-3p Nephroblastoma MNDR-E-MI-42115
MNDR hsa-miR-342-3p Colon cancer MNDR-E-MI-42116
MNDR hsa-miR-342-3p Colon adenocarcinoma MNDR-E-MI-42117
MNDR hsa-miR-342-3p Relapsing-remitting multiple sclerosis MNDR-E-MI-42118
MNDR hsa-miR-342-3p Familial ovarian cancer MNDR-E-MI-42119
MNDR hsa-miR-342-3p Prostate adenocarcinoma MNDR-E-MI-42120
MNDR hsa-miR-342-3p Kidney cancer MNDR-E-MI-42121
MNDR hsa-miR-342-3p Carcinoma ductal breast MNDR-E-MI-42122
MNDR hsa-miR-342-3p Glioblastoma MNDR-E-MI-42123
MNDR hsa-miR-342-3p Glioma MNDR-E-MI-42124
MNDR hsa-miR-342-3p Chordoma MNDR-E-MI-42125
MNDR hsa-miR-342-3p Amyotrophic lateral sclerosis MNDR-E-MI-42126
MNDR hsa-miR-342-3p Osteosarcoma MNDR-E-MI-42127
MNDR hsa-miR-342-3p Breast carcinoma MNDR-E-MI-42128
MNDR hsa-miR-342-3p Pancreatic ductal adenocarcinoma MNDR-E-MI-42129
MNDR hsa-miR-342-3p Meningioma MNDR-E-MI-42130
MNDR hsa-miR-342-3p Liver cancer MNDR-E-MI-42131
MNDR hsa-miR-342-3p Gastric adenocarcinoma MNDR-E-MI-42132
MNDR hsa-miR-342-3p Lung squamous cell carcinoma MNDR-E-MI-42133
MNDR hsa-miR-342-3p Carcinoma lung non-small-cell MNDR-E-MI-42134
MNDR hsa-miR-342-3p Lung adenocarcinoma MNDR-E-MI-42135
MNDR hsa-miR-342-3p Thyroid carcinoma MNDR-E-MI-42136
MNDR hsa-miR-342-3p Cervical cancer MNDR-E-MI-42137
MNDR hsa-miR-342-3p Myasthenia gravis autoimmune experimental MNDR-E-MI-42138
MNDR hsa-miR-342-3p Carcinoma renal cell MNDR-E-MI-42139
MNDR hsa-miR-342-3p Kidney renal papillary cell carcinoma MNDR-E-MI-42140
MNDR hsa-miR-342-3p Clear cell renal cell carcinoma MNDR-E-MI-42141
MNDR hsa-miR-342-3p Cholangiocarcinoma MNDR-E-MI-42142
MNDR hsa-miR-342-3p Lung small cell carcinoma MNDR-E-MI-42143
MNDR hsa-miR-342-3p Variant creutzfeldt-jakob disease MNDR-E-MI-42144
MNDR hsa-miR-342-3p Head and neck squamous cell carcinoma MNDR-E-MI-42145
MNDR hsa-miR-342-3p T acute lymphoblastic leukemia MNDR-E-MI-42146
MNDR hsa-miR-342-3p Acute t cell leukemia MNDR-E-MI-42147
MNDR hsa-miR-342-3p Prion disease MNDR-E-MI-42148
MNDR hsa-miR-342-3p Breast invasive carcinoma MNDR-E-MI-42149
MNDR hsa-miR-342-3p Hepatocellular carcinoma MNDR-E-MI-42150
MNDR hsa-miR-342-3p Familiar ovarian carcinoma MNDR-E-MI-42151
MNDR hsa-miR-342-3p B-cell lymphoma MNDR-E-MI-42152
MNDR hsa-miR-342-3p Rheumatoid arthritis MNDR-E-MI-42153
MNDR hsa-miR-342-3p T-cell leukemia MNDR-E-MI-42154
MNDR hsa-miR-342-3p Malignant pleural mesothelioma MNDR-E-MI-42155
MNDR hsa-miR-342-3p Retinoblastoma MNDR-E-MI-42156
MNDR hsa-miR-342-3p Neuroblastoma MNDR-E-MI-42157
MNDR hsa-miR-342-3p Hodgkin lymphoma MNDR-E-MI-42158
MNDR hsa-miR-342-3p Burkitt lymphoma MNDR-E-MI-42159
MNDR hsa-miR-342-3p Tonsil cancer MNDR-E-MI-42160
MNDR hsa-miR-342-3p Neuromyelitis optica MNDR-E-MI-42161
MNDR hsa-miR-342-3p Skin cutaneous melanoma MNDR-E-MI-42162
MNDR hsa-miR-342-3p Skin melanoma MNDR-E-MI-42163
MNDR hsa-miR-342-3p Colorectal cancer MNDR-E-MI-42164
MNDR hsa-miR-342-3p Nasopharynx carcinoma MNDR-E-MI-42165
MNDR hsa-miR-342-3p Multiple myeloma MNDR-E-MI-42166
MNDR hsa-miR-342-3p Uterine cervical neoplasms MNDR-E-MI-42167
MNDR hsa-miR-342-3p Nasopharyngeal cancer MNDR-E-MI-42168
MNDR hsa-miR-342-3p Prostatic neoplasms MNDR-E-MI-42169
MNDR hsa-miR-342-3p Sleep deprivation MNDR-E-MI-42170
MNDR hsa-miR-342-3p Epstein-barr virus infections MNDR-E-MI-42171
MNDR hsa-miR-342-3p Subarachnoid hemorrhage traumatic MNDR-E-MI-42172
MNDR hsa-miR-342-3p Intracranial hemorrhage hypertensive MNDR-E-MI-42173
MNDR hsa-miR-342-3p Stroke lacunar MNDR-E-MI-42174
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ANKRD49 Homo sapiens RR00081534
TOP